重药控股
(000950)
| 流通市值：92.80亿 | | | 总市值：92.80亿 |
| 流通股本：17.28亿 | | | 总股本：17.28亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 62,211,401,881.27 | 41,188,217,331.84 | 20,612,096,609.18 | 80,561,531,747.38 |
| 营业收入 | 62,211,401,881.27 | 41,188,217,331.84 | 20,612,096,609.18 | 80,561,531,747.38 |
| 利息收入 | - | - | - | 0 |
| 已赚保费 | - | - | - | 0 |
| 手续费及佣金收入 | - | - | - | 0 |
| 二、营业总成本 | 61,116,440,262.49 | 40,415,012,353.64 | 20,226,976,660.08 | 79,839,411,726.2 |
| 营业成本 | 57,722,565,015.73 | 38,177,845,488.73 | 19,127,985,333.13 | 74,572,958,281.08 |
| 税金及附加 | 144,014,156.18 | 95,633,246.59 | 44,546,150.3 | 197,932,772.83 |
| 销售费用 | 1,528,234,592.06 | 1,009,394,271.8 | 483,361,355.08 | 2,400,059,706 |
| 管理费用 | 1,163,604,488.01 | 752,371,295.81 | 399,386,855.68 | 1,583,861,371.92 |
| 研发费用 | 114,779.91 | 114,779.91 | 106,918.22 | 318,557.17 |
| 财务费用 | 557,907,230.6 | 379,653,270.8 | 171,590,047.67 | 1,084,281,037.2 |
| 其中:利息费用 | 586,844,710.86 | 399,397,135.84 | 187,365,511.58 | 1,137,829,179.76 |
| 其中:利息收入 | 51,046,224.71 | 36,129,431.83 | 21,476,986.75 | 85,781,932.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -861,030.74 | -861,030.74 | -861,030.74 | 6,919,028.26 |
| 加:投资收益 | 139,991,780.84 | 58,201,620.47 | 49,857,971.07 | 402,412,494.38 |
| 净敞口套期收益 | - | - | - | 0 |
| 汇兑收益 | - | - | - | 0 |
| 资产处置收益 | 1,831,874.32 | 1,202,756.45 | 521,195.79 | 10,534,476.58 |
| 资产减值损失(新) | -19,865,155.34 | -2,991,945.06 | -2,333,195.83 | -89,974,837.74 |
| 信用减值损失(新) | -572,285,350.1 | -374,439,753.39 | -226,100,551.55 | -524,008,924.77 |
| 其他收益 | 21,397,042.31 | 17,084,722.79 | 7,816,452.2 | 34,638,779.78 |
| 四、营业利润 | 665,170,780.07 | 471,401,348.72 | 214,020,790.04 | 562,641,037.67 |
| 加:营业外收入 | 7,803,703.27 | 6,406,692.87 | 1,487,612.65 | 27,011,954.57 |
| 减:营业外支出 | 15,538,263.58 | 10,563,402.91 | 4,176,197.8 | 32,144,744.79 |
| 五、利润总额 | 657,436,219.76 | 467,244,638.68 | 211,332,204.89 | 557,508,247.45 |
| 减:所得税费用 | 125,058,396.45 | 78,256,285.25 | 38,827,000.41 | 155,716,787.72 |
| 六、净利润 | 532,377,823.31 | 388,988,353.43 | 172,505,204.48 | 401,791,459.73 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 532,377,823.31 | 388,988,353.43 | 172,505,204.48 | 401,791,459.73 |
| 终止经营净利润 | - | - | - | 0 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 384,010,323.39 | 282,265,967.39 | 125,235,079.12 | 282,993,622.91 |
| 少数股东损益 | 148,367,499.92 | 106,722,386.04 | 47,270,125.36 | 118,797,836.82 |
| 扣除非经常损益后的净利润 | 379,481,776.48 | 276,856,201.49 | 121,916,362.72 | 202,048,462.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.22 | 0.16 | 0.07 | 0.16 |
| (二)稀释每股收益 | 0.22 | 0.16 | 0.07 | 0.16 |
| 八、其他综合收益 | -7,482,030.39 | -13,831,098.39 | - | -21,981,302.9 |
| 归属于母公司股东的其他综合收益 | -7,540,554.64 | -13,889,622.64 | - | -20,830,560.64 |
| 九、综合收益总额 | 524,895,792.92 | 375,157,255.04 | 172,505,204.48 | 379,810,156.83 |
| 归属于母公司股东的综合收益总额 | 376,469,768.75 | 268,376,344.75 | 125,235,079.12 | 262,163,062.27 |
| 归属于少数股东的综合收益总额 | 148,426,024.17 | 106,780,910.29 | 47,270,125.36 | 117,647,094.56 |
| 公告日期 | 2025-10-28 | 2025-08-21 | 2025-04-24 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |